Delivering vaccines directly to the lungs can boost immune responses to respiratory infections or lung cancer.

MIT researchers have developed a new vaccination strategy that can create an army of T cells that can protect mucosal surfaces such as the lungs. Read more…

Previous
Previous

Massachusetts should have a centralized ‘hub’ to help women entrepreneurs, report says

Next
Next

Without these lipid shells, there would be no mRNA vaccines for COVID-19